Grapevine: Biocon, Shriram Finance plan to sell units; Footpath Ventures eyes IPL franchise

By Sreeja Biswas

  • 15 Dec 2023
Premium

Biocon Ltd is considering a plan to sell its generic active pharmaceutical ingredient (API) business to lower its debt, a media report said.  The generic API business is worth around $1.5 billion, The Economic Times reported, citing people familiar with the matter.  The report said that Biocon has engaged in discussions with ......

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Already a member? Click here to log in.